Provides the data set from the Evi-Dem study, to promote data on the circumstances, services, costs, and outcomes of people in later stage dementia and their carers living at home in 17 areas of Engla
*Based on assumptions for efficacy, durability, toxicity, and cost in Methods and Table 1. Life expectancy, QALYs, and costs all discounted at 3%/year. ART: antiretroviral therapy; QALY: Quality-adjus
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to the elderly. Of paramount importance -- often unaccounted for in budget estimates -- are the saluta
Ce rapport présente un ensemble de politiques pouvant aider les pays à améliorer l’efficience des systèmes de santé et ainsi à obtenir un meilleur rapport qualité/prix dans les soins.
Organisation for Economic Co-operation and Development40
